GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a...


GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a share. HGSI shares +3%. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs